Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity
Mario Villa-González, Marina Rubio, Gerardo Martín-López, Paula R. Mallavibarrena, Laura Vallés‐Saiz, Denis Vivien, Francisco G. Wandosell, María José Pérez-Álvarez
This study shows that mTORC1 inhibition with rapamycin reduces brain damage and neuronal loss after ischemia by modulating microglial reactivity.
Biology Direct · Apr 6, 2024Peer-reviewedNeuroscience